GENE ONLINE|News &
Opinion
Blog

Urothelial Carcinoma
Deals MerckBavencio
Merck Regains Worldwide Rights to BAVENCIO After Parting Ways with Pfizer
2023-03-29
Trials & Approvals Bladder Cancer
Astellas Submits New Drug Application Targeting First ADC Approval for Metastatic Urothelial Cancer in Japan
2021-03-13
Trials & Approvals Bladder Cancer
AstraZeneca Voluntarily Withdraws Checkpoint Inhibitor Approved for Bladder Cancer Indication
2021-02-25
Trials & Approvals Bladder Cancer
Bavencio Bags FDA Approval as First-line Maintenance Treatment for Urothelial Carcinoma
2020-07-05
R&D
ASCO 2020: Maintenance Therapy with Avelumab Post-Chemo Improves Overall Survival of Bladder Cancer Patients
2020-05-29
R&D Antibody-Drug Conjugate
Padcev Keytruda Combo Garners Breakthrough Therapy Designation for Urothelial Cancer
2020-02-20
LATEST
Crossing Borders for a New Era in Healthcare Quality: Highlights from the 1st Asia Pacific Forum on Healthcare Quality
2024-12-12
Precision Medicine in Breast & Lung Cancer: Coordinated Diagnostics and Treatment Approaches for Personalized Care
2024-12-12
Fighting the Good Fight: Global Experts Unite to Share Oncology Breakthroughs at Asia-Pacific Precision Cancer Treatment Forum
2024-12-12
AI-Powered Blood Test Achieves 98% Accuracy in Early Breast Cancer Detection
2024-12-11
Taiwan’s Vice President Hsiao Bi-Khim Advocates Innovations in Medtech, Biotech, and Healthtech
2024-12-11
Six Game-Changing Cancer Treatments Built for Unstoppable Growth in 2025 – Part II
2024-12-11
Six Game-Changing Cancer Treatments Built for Unstoppable Growth in 2025 – Part I
2024-12-11
READ MORE
EVENT
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top